Magellan Health Company Profile (NASDAQ:MGLN)

About Magellan Health (NASDAQ:MGLN)

Magellan Health logoMagellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care - NEC
  • Sub-Industry: Managed Health Care
  • Symbol: NASDAQ:MGLN
  • CUSIP: 55907920
  • Web:
  • Market Cap: $1.89856 billion
  • Outstanding Shares: 23,716,000
Average Prices:
  • 50 Day Moving Avg: $73.37
  • 200 Day Moving Avg: $72.02
  • 52 Week Range: $49.50 - $84.71
  • Trailing P/E Ratio: 23.37
  • Foreward P/E Ratio: 16.33
  • P/E Growth: -11.22
Sales & Book Value:
  • Annual Revenue: $5.03 billion
  • Price / Sales: 0.38
  • Book Value: $47.71 per share
  • Price / Book: 1.67
  • EBIDTA: $245.9 million
  • Net Margins: 1.64%
  • Return on Equity: 9.05%
  • Return on Assets: 4.21%
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 1.25%
  • Quick Ratio: 1.19%
  • Average Volume: 139,186 shs.
  • Beta: 0.59
  • Short Ratio: 1.26

Frequently Asked Questions for Magellan Health (NASDAQ:MGLN)

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) issued its quarterly earnings results on Wednesday, April, 26th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.70 by $0.04. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.33 billion. Magellan Health had a return on equity of 9.05% and a net margin of 1.64%. Magellan Health's revenue for the quarter was up 16.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.79 earnings per share. View Magellan Health's Earnings History.

When will Magellan Health make its next earnings announcement?

Magellan Health is scheduled to release their next quarterly earnings announcement on Friday, July, 28th 2017. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided EPS guidance of $5.08-5.99 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.37. The company issued revenue guidance of $5.795-6.095 billion, compared to the consensus revenue estimate of $5.86 billion.

Where is Magellan Health's stock going? Where will Magellan Health's stock price be in 2017?

4 brokerages have issued twelve-month price objectives for Magellan Health's shares. Their predictions range from $69.00 to $91.00. On average, they anticipate Magellan Health's share price to reach $80.25 in the next year. View Analyst Ratings for Magellan Health.

What are analysts saying about Magellan Health stock?

Here are some recent quotes from research analysts about Magellan Health stock:

  • 1. According to Zacks Investment Research, "Magellan Health Services is the country's leading behavioral managed care organization. Its customers include health plans, corporations and government agencies. " (7/18/2017)
  • 2. Jefferies Group LLC analysts commented, "We believe mixed 4Q results and a small EPS guidance reduction (share count related) on the heels of MGLN's 50%+ surge (vs S&P's +10%) since early November are causing shares to pull back today (down 7-8% vs S&P's -0.2%). 4Q16 revenue was soft, but that's largely due to a short delay in starting new work. We think fundamentals remain broadly strong and remain Buy rated, but we modestly reduce our earnings projections and PT for higher Pharmacy uncertainty." (2/24/2017)

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:

  • Barry Michael Smith, Executive Chairman of the Board, Chief Executive Officer
  • Mostafa Kamal, Chief Executive Officer of Magellan Rx Management
  • Sanjeev K. Srivastava, Chief Executive Officer - Magellan Healthcare
  • Caskie R. Lewis-Clapper, Chief Human Resource Officer
  • Daniel N. Gregoire, General Counsel, Secretary
  • William J. McBride, Lead Independent Director
  • John O. Agwunobi M.D., Independent Director
  • Eran Broshy, Independent Director
  • Michael S. Diament, Independent Director
  • Perry G. Fine M.D., Independent Director

Who owns Magellan Health stock?

Magellan Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (3.06%), Bank of Montreal Can (0.87%), Peregrine Capital Management LLC (0.66%), Smith Graham & Co. Investment Advisors LP (0.64%), First Quadrant L P CA (0.15%) and Nisa Investment Advisors LLC (0.09%). Company insiders that own Magellan Health stock include Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West and Jonathan N Rubin. View Institutional Ownership Trends for Magellan Health.

Who sold Magellan Health stock? Who is selling Magellan Health stock?

Magellan Health's stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Smith Graham & Co. Investment Advisors LP and Capstone Asset Management Co.. Company insiders that have sold Magellan Health stock in the last year include Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West and Jonathan N Rubin. View Insider Buying and Selling for Magellan Health.

Who bought Magellan Health stock? Who is buying Magellan Health stock?

Magellan Health's stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Peregrine Capital Management LLC, Eqis Capital Management Inc., State of Alaska Department of Revenue, Aperio Group LLC, Alpha Windward LLC, Louisiana State Employees Retirement System and Nisa Investment Advisors LLC. View Insider Buying and Selling for Magellan Health.

How do I buy Magellan Health stock?

Shares of Magellan Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of Magellan Health stock can currently be purchased for approximately $79.85.

MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)
Community Ranking:  2.6 out of 5 ( )
Outperform Votes:  164 (Vote Outperform)
Underperform Votes:  155 (Vote Underperform)
Total Votes:  319
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Magellan Health (NASDAQ:MGLN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $80.25 (0.50% upside)

Analysts' Ratings History for Magellan Health (NASDAQ:MGLN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/13/2017KeyCorpUpgradeSector Weight -> Overweight$91.00HighView Rating Details
6/25/2017Leerink SwannReiterated RatingOutperform$68.00 -> $73.00LowView Rating Details
2/24/2017Jefferies Group LLCLower Price TargetBuy$89.00 -> $88.00N/AView Rating Details
11/23/2016Barclays PLCBoost Price TargetUnderweight$61.00 -> $69.00N/AView Rating Details
(Data available from 7/22/2015 forward)


Earnings History for Magellan Health (NASDAQ:MGLN)
Earnings by Quarter for Magellan Health (NASDAQ:MGLN)
Earnings History by Quarter for Magellan Health (NASDAQ MGLN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q1 2017$0.70$0.74$1.33 billion$1.31 billionViewN/AView Earnings Details
2/24/2017Q416$1.68$1.80$1.33 billion$1.26 billionViewN/AView Earnings Details
11/9/2016Q316$0.67$1.39$1.22 billion$1.29 billionViewListenView Earnings Details
7/29/2016Q216$0.62$0.58$1.15 billion$1.16 billionViewListenView Earnings Details
5/5/2016Q116$0.55$0.54$1.04 billion$1.12 billionViewN/AView Earnings Details
2/29/2016Q415$0.83$1.39$1.23 billion$1.27 billionViewListenView Earnings Details
10/27/2015Q315$0.49$0.53$1.19 billion$1.19 billionViewListenView Earnings Details
7/27/2015Q215$0.38$0.17$1.09 billion$1.16 billionViewListenView Earnings Details
4/30/2015Q115$0.38$0.73$1.02 billion$981.00 millionViewN/AView Earnings Details
2/26/2015Q414$0.49$1.04$980.37 million$982.50 millionViewListenView Earnings Details
10/24/2014Q314$0.44$1.09$930.10 million$823.20 millionViewListenView Earnings Details
7/25/2014Q214$0.56$0.25$863.10 million$888.00 millionViewListenView Earnings Details
4/29/2014Q114$0.75$0.92$1,000.00 million$966.50 millionViewListenView Earnings Details
3/3/2014Q413$0.83$0.67$990.55 million$1.01 millionViewN/AView Earnings Details
10/24/2013Q313$1.01$1.70$875.26 million$873.60 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.01$1.15$852.42 million$842.70 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.88$1.01$864.04 million$821.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$1.05$1.32$835.55 million$830.30 millionViewN/AView Earnings Details
10/26/2012Q312$0.96$1.12$845.16 million$798.40 millionViewN/AView Earnings Details
7/27/2012$0.91$0.97ViewN/AView Earnings Details
4/27/2012$0.90$0.75ViewN/AView Earnings Details
2/28/2012$0.77$1.05ViewN/AView Earnings Details
10/27/2011$0.84$1.03ViewN/AView Earnings Details
7/29/2011$0.86$1.07ViewN/AView Earnings Details
4/29/2011$0.79$1.02ViewN/AView Earnings Details
2/24/2011$0.91$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Magellan Health (NASDAQ:MGLN)
2017 EPS Consensus Estimate: $4.13
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.66$0.87$0.75
Q2 20173$0.85$0.92$0.89
Q3 20173$0.86$1.19$1.02
Q4 20173$1.36$1.61$1.47
(Data provided by Zacks Investment Research)


Dividend History for Magellan Health (NASDAQ:MGLN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Magellan Health (NASDAQ:MGLN)
Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 94.05%
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Institutional Ownership by Quarter for Magellan Health (NASDAQ:MGLN)
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/20/2017Daniel N GregoireGeneral CounselSell16,073$80.06$1,286,804.38View SEC Filing  
7/20/2017Jeffrey N WestSVPSell1,109$80.01$88,731.09View SEC Filing  
7/17/2017Jeffrey N WestSVPSell28,514$80.07$2,283,115.98View SEC Filing  
7/14/2017Daniel N GregoireGeneral CounselSell14,114$80.11$1,130,672.54View SEC Filing  
2/24/2017Jeffrey N WestSVPSell13,512$80.31$1,085,148.72View SEC Filing  
2/23/2017Eran BroshyDirectorSell4,867$80.00$389,360.00View SEC Filing  
2/3/2017Jeffrey N WestSVPSell15,055$76.46$1,151,105.30View SEC Filing  
2/1/2017Jeffrey N WestSVPSell3,346$76.05$254,463.30View SEC Filing  
12/8/2016Clapper Caskie LewisInsiderSell55,590$74.43$4,137,563.70View SEC Filing  
12/7/2016Jonathan N RubinCFOSell42,966$73.27$3,148,118.82View SEC Filing  
12/5/2016Jonathan N RubinCFOSell1,600$73.05$116,880.00View SEC Filing  
12/1/2016Jonathan N RubinCFOSell1,150$73.23$84,214.50View SEC Filing  
11/30/2016Jonathan N RubinCFOSell7,620$73.01$556,336.20View SEC Filing  
11/29/2016Jonathan N RubinCFOSell7,177$73.01$523,992.77View SEC Filing  
7/12/2016Jeffrey N WestSVPBuy267$51.99$13,881.33View SEC Filing  
1/15/2016Jeffrey N WestSVPBuy105$52.41$5,503.05View SEC Filing  
7/15/2015Jeffrey N WestSVPBuy298$50.22$14,965.56View SEC Filing  
3/19/2015Daniel N GregoireGeneral CounselSell26,232$68.47$1,796,105.04View SEC Filing  
3/16/2015Daniel N GregoireGeneral CounselSell15,528$66.80$1,037,270.40View SEC Filing  
3/16/2015Jonathan N RubinCFOSell21,270$66.59$1,416,369.30View SEC Filing  
3/13/2015Daniel N GregoireGeneral CounselSell9,765$66.21$646,540.65View SEC Filing  
3/2/2015Daniel N GregoireGeneral CounselSell20,365$64.48$1,313,135.20View SEC Filing  
6/30/2014Daniel N GregoireGeneral CounselSell21,675$62.25$1,349,268.75View SEC Filing  
6/26/2014Jonathan N RubinCFOSell29,700$61.92$1,839,024.00View SEC Filing  
6/25/2014Jonathan N RubinCFOSell18,400$62.40$1,148,160.00View SEC Filing  
6/24/2014Jonathan N RubinCFOSell19,200$62.46$1,199,232.00View SEC Filing  
6/23/2014Jonathan N RubinCFOSell21,700$62.73$1,361,241.00View SEC Filing  
6/20/2014Jonathan N RubinCFOSell31,200$62.99$1,965,288.00View SEC Filing  
6/19/2014Jonathan N RubinCFOSell18,600$62.73$1,166,778.00View SEC Filing  
6/18/2014Jonathan N RubinCFOSell35,896$62.79$2,253,909.84View SEC Filing  
6/17/2014Jonathan N RubinCFOSell23,996$62.22$1,493,031.12View SEC Filing  
6/16/2014Jonathan N RubinCFOSell13,041$62.18$810,889.38View SEC Filing  
6/16/2014Tina BlasiCEOSell10,775$62.07$668,804.25View SEC Filing  
6/13/2014Tina BlasiCEOSell10,247$62.03$635,621.41View SEC Filing  
5/19/2014Barry SmithCEOBuy10,000$58.56$585,600.00View SEC Filing  
5/14/2014Robert LeblancDirectorBuy10,000$55.60$556,000.00View SEC Filing  
3/6/2014Tina BlasiCEOSell10,527$60.42$636,041.34View SEC Filing  
12/20/2013Daniel GregoireGeneral CounselSell10,631$58.00$616,598.00View SEC Filing  
12/3/2013Rene LererChairmanSell28,321$61.01$1,727,864.21View SEC Filing  
12/2/2013Rene LererChairmanSell36,000$61.30$2,206,800.00View SEC Filing  
11/26/2013Rene LererChairmanSell5,055$60.75$307,091.25View SEC Filing  
11/22/2013Rene LererChairmanSell14,700$60.67$891,849.00View SEC Filing  
11/18/2013Rene LererChairmanSell33,215$61.34$2,037,408.10View SEC Filing  
11/14/2013Rene LererDirectorSell52,541$59.99$3,151,934.59View SEC Filing  
11/12/2013Rene LererChairmanSell36,500$59.34$2,165,910.00View SEC Filing  
11/8/2013Rene LererChairmanSell15,200$59.62$906,224.00View SEC Filing  
11/6/2013Rene LererChairmanSell96,773$59.27$5,735,735.71View SEC Filing  
11/4/2013Rene LererChairmanSell62,900$59.01$3,711,729.00View SEC Filing  
10/24/2013Tina BlasiCEOSell12,331$62.00$764,522.00View SEC Filing  
7/11/2013Jonathan N RubinCFOSell24,500$57.53$1,409,485.00View SEC Filing  
7/9/2013Jonathan N RubinCFOSell27,950$57.92$1,618,864.00View SEC Filing  
7/8/2013Jonathan N RubinCFOSell6,150$57.05$350,857.50View SEC Filing  
6/19/2013Jonathan N RubinCFOSell1,600$57.06$91,296.00View SEC Filing  
6/3/2013Clapper Caskie LewisInsiderSell43,399$55.00$2,386,945.00View SEC Filing  
5/31/2013Clapper Caskie LewisInsiderSell14,002$55.00$770,110.00View SEC Filing  
10/5/2012Tina BlasiCEOSell3,000$52.06$156,180.00View SEC Filing  
10/3/2012Tina BlasiCEOSell1,955$52.03$101,718.65View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Magellan Health (NASDAQ:MGLN)
Latest Headlines for Magellan Health (NASDAQ:MGLN)
DateHeadline logoMagellan Health, Inc. (NASDAQ:MGLN) SVP Jeffrey N. West Sells 1,109 Shares - July 21 at 4:26 PM logoDaniel N. Gregoire Sells 16,073 Shares of Magellan Health, Inc. (NASDAQ:MGLN) Stock - July 21 at 4:26 PM logoMagellan Health, Inc. (MGLN) Expected to Post Quarterly Sales of $1.40 Billion - July 21 at 1:16 PM logoMagellan Health, Inc. (NASDAQ:MGLN) Expected to Announce Earnings of $0.94 Per Share - July 19 at 10:10 PM logoInsider Selling: Magellan Health, Inc. (NASDAQ:MGLN) SVP Sells 28,514 Shares of Stock - July 18 at 4:18 PM logoInsider Selling: Magellan Health, Inc. (NASDAQ:MGLN) General Counsel Sells 14,114 Shares of Stock - July 17 at 7:14 PM logoFY2018 Earnings Estimate for Magellan Health, Inc. (MGLN) Issued By KeyCorp - July 17 at 10:30 AM logoLeerink Swann Analysts Decrease Earnings Estimates for Magellan Health, Inc. (MGLN) - July 17 at 7:40 AM logoMagellan Health, Inc. (NASDAQ:MGLN) Lifted to "Overweight" at KeyCorp - July 16 at 5:14 PM logoMagellan Health (MGLN) Looks Good: Stock Adds 6.01% in Session - July 15 at 6:25 AM logoMagellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health - July 14 at 6:25 AM logo[$$] Magellan to Acquire TA Associates-Backed Senior Whole Health for $400 Million - July 14 at 6:25 AM logoMagellan Health to Acquire Senior Whole Health - July 13 at 6:43 AM logoMagellan Health Provides Free Counseling Services and Resources to Individuals Impacted by Wildfires in California - July 12 at 3:27 AM logoMagellan Health, Inc. (NASDAQ:MGLN) Given Consensus Recommendation of "Hold" by Brokerages - July 4 at 2:38 PM logoMagellan Health Announces Second Quarter 2017 Earnings Conference Call - June 28 at 8:59 AM logoMagellan Health, Inc. (MGLN) Stock Rating Reaffirmed by Leerink Swann - June 25 at 11:20 AM logo$1.40 Billion in Sales Expected for Magellan Health, Inc. (MGLN) This Quarter - June 25 at 8:16 AM logo$0.96 Earnings Per Share Expected for Magellan Health, Inc. (MGLN) This Quarter - June 23 at 6:20 PM logoETFs with exposure to Magellan Health, Inc. : June 15, 2017 - June 16 at 7:44 AM logoMagellan Health, Inc. (MGLN) Upgraded to "Hold" by BidaskClub - June 13 at 10:26 PM logoMagellan Health Inc (MGLN) Short Interest Up 6.3% in May - June 11 at 12:46 PM logoMagellan Health Inc (MGLN) Given Average Recommendation of "Hold" by Analysts - June 9 at 4:48 PM logoMagellan Health Provides Free Counseling Services and Resources to Individuals Impacted by Shootings at Orlando Workplace - June 6 at 9:30 AM logoMagellan Health, Inc. breached its 50 day moving average in a Bullish Manner : MGLN-US : June 2, 2017 - June 2 at 7:54 PM logo$1.40 Billion in Sales Expected for Magellan Health Inc (MGLN) This Quarter - June 1 at 11:14 AM logoZacks: Analysts Anticipate Magellan Health Inc (MGLN) Will Post Earnings of $0.96 Per Share - May 30 at 2:10 PM logoMagellan Health, Inc. breached its 50 day moving average in a Bearish Manner : MGLN-US : May 19, 2017 - May 19 at 11:05 AM logo[$$] Frazier Healthcare Adds Senior Adviser - May 16 at 6:20 PM logoMagellan Health Inc (MGLN) Receives Consensus Rating of "Hold" from Analysts - May 15 at 12:46 PM logoPost Earnings Coverage as Aetna's Adjusted EPS Jumped 17% - May 15 at 10:26 AM logoMagellan Health to Participate in Jefferies 2017 Global Healthcare Conference - May 11 at 7:00 PM logoMagellan Health to Present at Barclays Pharmacy Benefit Management & Drug Pricing Symposium - May 9 at 11:49 AM logo$0.88 Earnings Per Share Expected for Magellan Health Inc (MGLN) This Quarter - May 4 at 8:32 PM logoBrokers Offer Predictions for Magellan Health Inc's FY2018 Earnings (MGLN) - May 4 at 7:06 PM logoMagellan Health, Inc. breached its 50 day moving average in a Bearish Manner : MGLN-US : May 4, 2017 - May 4 at 11:39 AM logoMagellan Health (MGLN) Earns Daily Media Sentiment Rating of 0.37 - May 3 at 7:42 PM logoETFs with exposure to Magellan Health, Inc. : May 1, 2017 - May 1 at 5:32 PM logoMagellan Health Inc to Post Q2 2017 Earnings of $0.85 Per Share, Jefferies Group Forecasts (MGLN) - May 1 at 7:54 AM logoZacks Investment Research Upgrades Magellan Health Inc (MGLN) to "Hold" - April 30 at 7:59 PM logoMagellan Health (MGLN) Earns Daily Media Impact Rating of 0.56 - April 30 at 10:22 AM logoMagellan Health, Inc. :MGLN-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017 - April 28 at 7:27 PM logoMagellan Health Inc (MGLN) Upgraded to Hold at Zacks Investment Research - April 28 at 7:04 PM logoQ3 2017 Earnings Forecast for Magellan Health Inc (MGLN) Issued By Jefferies Group - April 28 at 1:22 PM logoEdited Transcript of MGLN earnings conference call or presentation 26-Apr-17 2:00pm GMT - April 27 at 7:04 PM logoMagellan Health (MGLN) Earning Very Positive Press Coverage, Study Finds - April 27 at 10:02 AM logoMagellan Health Reports First Quarter 2017 Financial Results - April 26 at 6:47 PM logoMagellan Health Inc (MGLN) Releases Earnings Results, Beats Estimates By $0.04 EPS - April 26 at 2:26 PM logoMagellan Health tops 1Q profit forecasts - April 26 at 11:40 AM logoMagellan Health, Inc. – Value Analysis (NASDAQ:MGLN) : April 25, 2017 - April 25 at 5:50 PM



Magellan Health (MGLN) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by Staff